Welcome to our dedicated page for The Beauty Health Company news (Ticker: SKIN), a resource for investors and traders seeking the latest updates and insights on The Beauty Health Company stock.
The Beauty Health Company (SKIN), innovator of Hydrafacial systems and advanced aesthetic technologies since 1997, provides this centralized hub for investors and industry professionals. Our news collection offers immediate access to verified corporate developments, combining regulatory filings with market analysis for complete transparency.
This resource serves as your primary source for tracking earnings announcements, product innovations, and strategic partnerships that shape the medical aesthetics sector. Users benefit from chronological organization of press releases alongside third-party analyses, maintaining balanced perspectives on company milestones.
Content spans critical updates including FDA clearances, international expansion efforts, and clinical study results. Each entry is vetted for relevance to investor priorities and industry trends, with particular emphasis on the company's serum-based technology advancements.
Bookmark this page for real-time updates on SKIN's market movements and professional-grade insights into the $18B global aesthetics industry. Cross-reference our archive with SEC filings using provided document identifiers for complete due diligence capabilities.
The Beauty Health Company (NASDAQ:SKIN) has updated its fiscal year 2021 outlook, expecting net sales to be near the high end of previous guidance at $245 million to $255 million. The company also reiterates its adjusted EBITDA expectation of approximately $30 million. Despite facing challenges from a new COVID variant, BeautyHealth's Executive Chairman, Brent Saunders, noted resilient growth and opportunities in the beauty health sector. Risks include potential impacts from market closures and rising costs.
The Beauty Health Company (NASDAQ:SKIN) has appointed Kellie Sears as its new Chief Human Resources Officer, effective immediately. With extensive global experience, Sears will lead human capital management, focusing on talent acquisition, diversity, and employee engagement. Executive Chairman Brent Saunders expressed optimism about Sears' impact on the company’s growth strategy. Previously, she held HR leadership roles at major companies including Allergan and Pfizer. BeautyHealth aims to strengthen its global workforce to support its successful HydraFacial brand, enhancing its market position.
The Beauty Health Company (NASDAQ:SKIN) announced that CFO Liyuan Woo will join a virtual fireside chat at the 2022 ICR Conference on January 11, 2022, at 9:30 am ET.
This event will be webcast live on the company's investor relations website, with an archived replay available later. BeautyHealth is known for its HydraFacial brand, which offers non-invasive skincare solutions using patented technology.
The Beauty Health Company (NASDAQ:SKIN) concludes its 2021 #GLOWvolution Tour this weekend in Times Square, after successfully traveling across the U.S. since June. The tour provided free HydraFacial treatments to thousands, significantly increasing brand engagement and social media impressions. The initiative extended beyond consumer engagement, offering educational resources for HydraFacialists. The success of the tour led to the addition of the NYC stop, showcasing the positive reception from the public and professionals in the beauty industry.
The Beauty Health Company (NASDAQ:SKIN) announced that Brent Saunders, Executive Chairman, and Liyuan Woo, CFO, will present at Piper Sandler’s 33rd Annual Virtual Healthcare Conference on November 22, 2021, at 10:00 a.m. ET. A webcast of the presentation will be available on the Company’s investor relations website, with an archived replay accessible afterward.
BeautyHealth focuses on innovative beauty products, with its flagship HydraFacial offering a non-invasive skin care solution available in over 87 countries.
The Beauty Health Company (NASDAQ: SKIN) announced the departure of CEO Clint Carnell, effective December 31, 2021, coinciding with a record third quarter performance. Brent Saunders, Executive Chairman, will serve as interim CEO until a permanent replacement is found. The transition is not related to financial concerns, and the company is focused on growth through brand awareness, innovation, and international expansion. Carnell expressed pride in his five-year tenure, during which he navigated the business through significant challenges.
The Beauty Health Company (NASDAQ:SKIN) reported impressive third-quarter results for 2021, with net sales of $68.1 million, a 97% increase from Q3 2020. The company raised its full-year revenue guidance to $245-$255 million, citing strong performance across the Americas and EMEA regions despite challenges from the Delta variant. Adjusted EBITDA stood at $5.8 million. However, net loss ballooned to $215.1 million due to non-cash liabilities. Overall, BeautyHealth remains optimistic about future growth potential amid ongoing market uncertainties.
The Beauty Health Company (NASDAQ:SKIN) has completed the redemption of all outstanding public warrants from its initial public offering. As of the Redemption Date, November 3, 2021, approximately 99.5% of the public warrants were exercised. This resulted in total cash proceeds of $185.4 million, with 16,123,235 warrants exercised for cash and 74,104 on a cashless basis. The public warrants were subsequently delisted from the Nasdaq. The company's common stock continues to trade under the ticker symbol 'SKIN'.
The Beauty Health Company (NASDAQ:SKIN) will announce its third quarter 2021 financial results after the market closes on November 9, 2021. A conference call is scheduled for 4:30 p.m. Eastern Time on the same day to discuss these results. Interested participants can join the call by dialing (877) 407-9208 for domestic calls or 1 (201) 493-6784 for international calls, using conference ID 13723615. A live audio webcast will also be available for access.
FAQ
What is the current stock price of The Beauty Health Company (SKIN)?
What is the market cap of The Beauty Health Company (SKIN)?
